ABBV $95.84 -0.79 (-0.82%)
AbbVie Stock Charts
The 5 year and 1 year stock charts are below.
50 Day Moving Average
The 50 Day Moving Average is at $99.02 which is 3.21% above the stock price of $95.84.
200 Day Moving Average
The 200 Day Moving Average is at 100.12 which is 4.27% above the stock price of $95.84.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
ABBV Stock Price
Below are a few key dates for the stock price.
Year To Date
The most recent stock price is $95.84.
The Year To Date (YTD) return is -2.61%.
52 Week Low
The 52 Week Low stock price is $69.38 set on Fri, Jul 28, 2017 which is 353 days ago.
The current price per share is 38.14% above the 52 week low.
52 Week High
The 52 Week High stock price is $125.86 set on Fri, Jan 26, 2018 which is 171 days ago.
The current price per share is -23.85% below the 52 week high.
All Time High
The All Time High stock price is $125.86 set on Fri, Jan 26, 2018 which is 171 days ago.
The current price per share is -23.85% below the all time high.
Below is the EPS, P/E Ratio and Earnings Date.
The Earnings Per Share (EPS) is $3.98.
The Price To Earnings (P/E) Ratio is 24.30.
AbbVie has a relatively low price to earnings ratio compared to the overal S&P 500 average, which is about 25%.
Some investors look for very low p/e stocks with the hopes of investing in an undervalued stock. Of course, this is just one factor to consider.
Stocks can make big percentage moves on the earnings announcement.
Companies announce earnings either before the market open or after the close.
The Earnings Release Date for AbbVie Inc was Thu, Apr 26, 2018.
Since this earnings release 81 days ago, the stock price is up by +4.32%.
The next Earnings Release Date is on Fri, Jul 27, 2018, which is in 11 days.2018-07-27 06:00:002018-07-27 13:00:00America/New_YorkAbbVie Inc (ABBV) EarningsVisit http://www.symbolsurfing.com/ABBV for more information.United StatesSymbol Surfinginfo@symbolsurfing.com
Below is important Dividend information.
The Annual Dividend Yield is 3.96%.
AbbVie Inc is one of the few S&P 500 Dividend Aristocrats stocks.
The Dividend Aristocrats are S&P 500 constituents that have increased their dividend payouts for 25 consecutive years. The companies that make up the Dividend Aristocrats span ten different business sectors with both growth and value holdings. Wikipedia
Check out the Dividend Calculator to forecast your potential profis with AbbVie.
(The next ex-dividend date will be around Wed, Oct 10, 2018.)
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.
|Declaration Date||Amount||Ex-Date||Record Date||Pay Date|
|Fri, Jun 15, 2018||$0.96||Thu, Jul 12, 2018||Fri, Jul 13, 2018||Wed, Aug 15, 2018|
|Thu, Feb 15, 2018||$0.96||Thu, Apr 12, 2018||Fri, Apr 13, 2018||Tue, May 15, 2018|
|Fri, Oct 27, 2017||$0.71||Thu, Jan 11, 2018||Fri, Jan 12, 2018||Thu, Feb 15, 2018|
|Fri, Sep 8, 2017||$0.64||Thu, Oct 12, 2017||Fri, Oct 13, 2017||Wed, Nov 15, 2017|
|Tue, Jun 27, 2017||$0.64||Wed, Jul 12, 2017||Fri, Jul 14, 2017||Tue, Aug 15, 2017|
|Thu, Feb 16, 2017||$0.64||Tue, Apr 11, 2017||Thu, Apr 13, 2017||Mon, May 15, 2017|
|Fri, Oct 28, 2016||$0.64||Wed, Jan 11, 2017||Fri, Jan 13, 2017||Wed, Feb 15, 2017|
|Fri, Sep 9, 2016||$0.57||Wed, Oct 12, 2016||Fri, Oct 14, 2016||Tue, Nov 15, 2016|
|Thu, Jun 16, 2016||$0.57||Wed, Jul 13, 2016||Fri, Jul 15, 2016||Mon, Aug 15, 2016|
|Thu, Feb 18, 2016||$0.57||Wed, Apr 13, 2016||Fri, Apr 15, 2016||Mon, May 16, 2016|
|Fri, Oct 30, 2015||$0.57||Wed, Jan 13, 2016||Fri, Jan 15, 2016||Tue, Feb 16, 2016|
|Fri, Sep 11, 2015||$0.51||Tue, Oct 13, 2015||Thu, Oct 15, 2015||Sat, Nov 14, 2015|
|Thu, Jun 18, 2015||$0.51||Mon, Jul 13, 2015||Wed, Jul 15, 2015||Fri, Aug 14, 2015|
|Thu, Feb 19, 2015||$0.51||Mon, Apr 13, 2015||Wed, Apr 15, 2015||Fri, May 15, 2015|
|Mon, Oct 20, 2014||$0.49||Tue, Jan 13, 2015||Thu, Jan 15, 2015||Fri, Feb 13, 2015|
|Fri, Sep 19, 2014||$0.42||Fri, Oct 10, 2014||Wed, Oct 15, 2014||Mon, Nov 17, 2014|
|Thu, Jun 19, 2014||$0.42||Fri, Jul 11, 2014||Tue, Jul 15, 2014||Fri, Aug 15, 2014|
|Thu, Feb 20, 2014||$0.42||Fri, Apr 11, 2014||Tue, Apr 15, 2014||Thu, May 15, 2014|
|Thu, Dec 12, 2013||$0.40||Mon, Jan 13, 2014||Wed, Jan 15, 2014||Fri, Feb 14, 2014|
|Thu, Sep 19, 2013||$0.40||Thu, Oct 10, 2013||Tue, Oct 15, 2013||Fri, Nov 15, 2013|
|Thu, Jun 20, 2013||$0.40||Thu, Jul 11, 2013||Mon, Jul 15, 2013||Thu, Aug 15, 2013|
|Fri, Feb 15, 2013||$0.40||Thu, Apr 11, 2013||Mon, Apr 15, 2013||Wed, May 15, 2013|
|Fri, Jan 4, 2013||$0.40||Fri, Jan 11, 2013||Tue, Jan 15, 2013||Fri, Feb 15, 2013|
Biotech & Pharma Industry
Below are other stocks in the same industry as AbbVie.
ABBV Company Profile
Learn more about AbbVie.
AbbVie Inc is a Health Care stock that trades on the NYSE and has a market capitalization of $152.61 Billion.
ABBV is also one of the largest companies by market capitalization today.
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).
Spend a few minutes browsing the AbbVie Inc, web site at https://www.abbvie.com.